Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:10 AM
Ignite Modification Date:
2025-12-25 @ 12:10 AM
NCT ID:
NCT01255358
Eligibility Criteria:
Inclusion Criteria:
* neurological signs of AT
* patients in autonomous gait or helped by a support
* proven molecular diagnosis of AT
* Males and females aged \> 3 years
* Body weight \>15 kg
* Plasma levels of Lymphocytes CD4+/mm3 \> 500 (for patients aged 3-6 years) or \> 200 (older than 6 years)
* written IC to participate.
Exclusion Criteria:
* Current or previous neoplastic disease
* History of severe impairment of the immunological system
* Chronic conditions representing a contraindication to the use of steroid drugs
* Non compliance with the study request
* Any previous steroid assumption within 30 days before starting ERY-DEX
* Have any other significant disease that in the Investigator's opinion would exclude the patient from the trial
* Females of childbearing potential who were pregnant, breast-feeding or were not using adequate contraceptive methods
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
3 Years
Study:
NCT01255358
Study Brief:
Protocol Section:
NCT01255358